Since its first detection in December 2019 in Wuhan, China, the disease caused by the SARS-CoV-2 virus, called COVID-19, has been shown to be highly infectious and contagious, with rapid dissemination, constituting a major public health problem across the world, but its clinical characteristics are still unknown. The clinical evolution of the disease basically consists of three stages, each lasting approximately one week. During the first, the clinical picture is characterized by dry cough, dyspnea, diarrhea, general malaise, and fever, which can progress to pneumonia (stage 2) and then acute respiratory distress syndrome (stage 3). Previous publications show that elderly people who suffer from COVID-19 and have chronic comorbidities, such as arterial hypertension, diabetes mellitus, or some chronic respiratory pathologies, have a greater risk of developing acute respiratory distress with multiorgan failure. The relationship between asthma and acute respiratory distress developed during COVID-19 disease needs to be better studied because it has been underreported
Journal of Asthma: